Ovarian cryopreservation and transplantation for fertility preservation for medical indications: report of an ongoing experience Kutluk Oktay, M.D.,

Slides:

Advertisements

Similar presentations

Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States David B. Seifer, M.D., Valerie.

Advertisements

What’s the delay? A qualitative study of women’s experiences of reaching a diagnosis of endometriosis Karen Ballard, Ph.D., Karen Lowton, Ph.D., Jeremy.

J.C. Trussell, M.D., Allen R. Kunselman, M.A., Richard S. Legro, M.D.

A giant oocyte in a cohort of retrieved oocytes: does it have any effect on the in vitro fertilization cycle outcome? Ronit Machtinger, M.D., Joseph.

Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment Javier Domingo, M.D., Vicente.

Cost-effectiveness of presumptively medically treating women at risk for ectopic pregnancy compared with first performing a dilatation and curettage

Age at menarche: a predictor of diminished ovarian function?

Akanksha Mehta, M.D., Mark Sigman, M.D. Fertility and Sterility

Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation.

Karl R. Hansen, M. D. , Ph. D. , George M. Hodnett, M. D

Fernando Zegers-Hochschild, M.D. Fertility and Sterility

Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase Michael von Wolff, M.D., Christian J. Thaler,

Michael M. Alper, M.D. Fertility and Sterility

Four spontaneous pregnancies and three live births following subcutaneous transplantation of frozen banked ovarian tissue: What is the explanation? Kutluk.

Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials Ana Cobo, Ph.D., César Diaz, M.D.

Dennis J. Hand, Ph. D. , Vanessa L. Short, Ph. D. , M. P. H. , Diane J

Hepatitis and reproduction

Ovarian pregnancy after in vitro fertilization

Sanghoon Lee, M. D. , Elke Heytens, Ph. D. , Fred Moy, Ph. D

Lauren Groskaufmanis, M.P.H., Saba W. Masho, M.D.

Medical treatment of ectopic pregnancy: a committee opinion

Isolation and Characterization of New Human Embryonic Stem Cell Lines on Mouse and Human Feeder Layers N. Findikli, S. Kahraman, O. Akcin, Z. Candan,

Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers Andrea.

Hakan Cakmak, M. D. , Audra Katz, R. N. , Marcelle I. Cedars, M. D

Cosmetics use and age at menopause: is there a connection?

How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization Robert L. Klitzman, M.D. Fertility.

Selection of patients for natural cycle in vitro fertilization combined with in vitro maturation of immature oocytes Jin-Ho Lim, M.D., Seong-Ho Yang,

Low fertility awareness in United States reproductive-aged women and medical trainees: creation and validation of the Fertility & Infertility Treatment.

Oocyte cryopreservation

Whole sheep ovary cryopreservation and transplantation

Do anti-mullerian hormone levels predict ovarian reserve in SLE patients presenting for hematopoietic stem cell transplant? H. Browne, A. Armstrong,

Robert F. Casper, M.D. Fertility and Sterility

Mieke Carine Wim Eeckhaut, Ph.D. Fertility and Sterility

Use of hormone suppression then oocyte freezing to preserve reproductive capability in an adolescent girl with ovarian luteinized thecoma associated with.

A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone

A nationwide survey of oncologists regarding treatment-related infertility and fertility preservation in female cancer patients Eric J. Forman, M.D.,

Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis Laura P. Smith, M.D.,

Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility Stephanie Beall, M.D., Ph.D., Alan H. DeCherney,

Clomiphene citrate at 50: the dawning of assisted reproduction

Mitchell P. Rosen, M. D. , Erica Johnstone, M. D. , Charles E

Maternal complication of cervical heterotopic pregnancy after successful potassium chloride fetal reduction Cynthia Gyamfi, M.D., Samantha Cohen, B.A.,

An employer's experience with infertility coverage: a case study

Age-specific probability of live birth with oocyte cryopreservation: an individual patient data meta-analysis Aylin Pelin Cil, M.D., Heejung Bang, Ph.D.,

Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D.

Eva Balkenende, Taghride Dahhan, M. D. , Fulco van der Veen, M. D, Ph

Role of treatment with ovarian stimulation and intrauterine insemination in women with unilateral tubal occlusion diagnosed by hysterosalpingography

Current approach to fertility preservation by embryo cryopreservation

Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities.

Prospective cohort study of three- versus two-dimensional ultrasound for prediction of oocyte maturity Doron Shmorgun, M.D., Edward Hughes, M.D., Patrick.

Ri-Cheng Chian, Ph.D., Peter S. Uzelac, M.D., Geeta Nargund, M.D.

Fertility and Sterility

P-425 Fertility and Sterility Volume 86, Issue 3, (September 2006)

Fertility preservation in girls with Turner syndrome: limitations, current success and future prospects Kutluk Oktay, M.D., Ph.D., Giuliano Bedoschi,

S. Samuel Kim, M.D. Fertility and Sterility

Website quality assessment: Mistaking apples for oranges

Heterotopic autotransplantation of cryobanked human ovarian tissue as a strategy to restore ovarian function S.Samuel Kim, M.D., In-Tak Hwang, M.D.,

L. Scott, J. Bernsten, K. DeLegge, J. Hill, N. Ramsing

Fertility and Sterility: an evaluation

Sedigheh Borna, M.D., Azita Nasery, M.D. Fertility and Sterility

Ovarian cystic teratoma with a pathognomonic appearance of multiple floating balls: a case report and investigation of common characteristics of the cases.

Current evaluation of amenorrhea

David H. Barad, M.D., M.S., Norbert Gleicher, M.D.

Ronald M. Yang, M. D. , Richard A. Fefferman, M. D. , Charles E

Aline Ketefian, M. D. , Jianfang Hu, Ph. D. , Alfred A. Bartolucci, Ph

Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories Melissa C. Yih, M.D.,

In vitro sildenafil citrate use as a sperm motility stimulant

Soluble HLA-G in the peritoneal fluid of women with endometriosis

Which patients pursue fertility preservation treatments

Progesterone level and progesterone/estradiol ratio on the day of hCG administration: detrimental cutoff levels and new treatment strategy Eman A. Elgindy,

Ovarian follicular volume and follicular surface area are better indicators of follicular growth and maturation, respectively, than is follicular diameter

Presentation transcript:

Ovarian cryopreservation and transplantation for fertility preservation for medical indications: report of an ongoing experience Kutluk Oktay, M.D., F.A.C.O.G., Ozgur Oktem, M.D. Fertility and Sterility Volume 93, Issue 3, Pages 762-768 (February 2010) DOI: 10.1016/j.fertnstert.2008.10.006 Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Distribution of ovarian cryopreservation cases by age groups. Note that 19% were less than the age of 18 years, and more than half were <30 years of age. Fertility and Sterility 2010 93, 762-768DOI: (10.1016/j.fertnstert.2008.10.006) Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions

Figure 2 Diagnoses (A) and treatment types (B) that indicated fertility preservation by ovarian cryopreservation. HSCT = hematopoietic stem cell transplantation. Fertility and Sterility 2010 93, 762-768DOI: (10.1016/j.fertnstert.2008.10.006) Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions

Figure 3 A mature oocyte obtained from the Hodgkin's lymphoma survivor who had undergone subcutaneous heterotopic ovarian transplantation in the lower abdomen. Fertility and Sterility 2010 93, 762-768DOI: (10.1016/j.fertnstert.2008.10.006) Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions